New Standard in Pathology

Hong Kong, Hong Kong

Short Summary

Currently there is a gap in pathology laboratory quality and process control for stained microscope slides. Process Record Slide (PRS) was specifically created to fill that gap. PRS has been FDA and CFDA cleared as calibrating consumable device.

Highlights

  • Control Targets Co-reside with Patients Samples
  • 100% QC is now Economically Viable
  • Calibrated Target Baseline enables True Quantifiable Diagnosis
  • The missing link to fulfill ISO 15189
  • The Only Solution to Digital Solution and Objective Diagnosis
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Overview

Target
HK$50,000,000
Minimum
HK$500,000
Investment Raised
N/A
Previous Rounds HK$3,000,000
Stage MVP/Finished Product
Investor Role Any

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 175,482 investors before you know it.

Create New Account
Already have an account?

Similar Projects

Pro
50% raised

Small Investment Opp

Hong Kong

Biorna Quantics is a preventative & personalised health-tech company that combines digital intelligence, health data, nutrition, exercise and education to make you, a better you. We give you full ownership of your health to put you ahead of the pack.

HK$ 2,000,000

Target

HK$ 50,000

Min per Investor

33% raised

Top Healthcare Investment

Midwest, USA

Capstone Health Network is disrupting & improving U.S. healthcare by letting 50M people consult with doctors from home 24/7/365 with no doctor bills, co-pays, or deductibles. $50k in R&D. $200k raised so far. High growth & ROI potential.

HK$ 4,700,000

Target

HK$ 78,000

Min per Investor

Global Pro
0% raised

Fiberlab - Europa

Im Ausland, Switzerland

Fiberlab ist ein Unternehmen die in den USA nach einem Jahr Betrieb schon in der Gewinnzone ist. Derzeit sind wir bemüht den Start in Europa zu vollziehen mit den Hauptsitz in Zürich/Schweiz. Das Investment soll den Start in Europa forcieren.

HK$ 9,000,000

Target

HK$ 4,500,000

Min per Investor

load one similar proposal
arrow_upward